Please use this identifier to cite or link to this item:
http://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2505
Title: | Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
Authors: | Galván Tejada, Carlos Erik Herrera García, Cintya Fabiola Godina González, Susana Villagrana Bañuelos, Karen E. De Luna Amaro, Juan Daniel Herrera García, Karla Rodríguez Quiñones, Carolina Zanella Calzada, Laura A. Ramírez Barranco, Julio Ruiz de Avila, Jocelyn L. Reyes Escobedo, Fuensanta Celaya Padilla, José María Galván Tejada, Jorge Issac Gamboa Rosales, Hamurabi Martínez Acuña, Mónica Cervantes Villagrana, Alberto Rivas Santiago, Bruno Gonzalez Curiel, Irma E. |
Issue Date: | 14-Dec-2020 |
Publisher: | MDPI |
Abstract: | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19. |
URI: | http://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2505 |
ISSN: | 1660-4601 |
Other Identifiers: | info:eu-repo/semantics/publishedVersion |
Appears in Collections: | *Documentos Académicos*-- M. en Ciencias y Tecnología Química |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
probatorio4.pdf | 425,73 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License